Canterbury DHB

Context

Management

In This Section

Key Points

Outline of Treatment for Severe AA

Supportive Care in Aplastic Anaemia

Stem Cell Transplantation

Immunosuppression - ATG/ALG and Cyclosporin

Relapsed / Refractory Disease

Moderate Aplastic Anaemia

About this Canterbury DHB document (4925):

Document Owner:

Mark Smith (see Who's Who)

Issue Date:

August 2017

Next Review:

August 2019

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 4925